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The regulation of chemical substances involves a negotiation between social 
actors to translate controversial scientific evidence about risks into legal norms. 
This chapter addresses the discussion elicited by a public consultation on a volun-
tary regulation guide on silver nanoparticles (AgNP) in workplaces. It examines the 
comments made from 2016 to 2018 by diverse social actors – business representa-
tives, non-governmental organizations (NGO), and independent researchers – to 
two successive draft versions of a Recommended Exposure Limit (REL) in working 
environments with AgNP. The REL is a voluntary guideline on permissible exposure 
limits elaborated by the NIOSH in the U.S. The methodology used was a qualitative 
content analysis, structured upon a historical and sociotechnical contextualization 
of nanotechnologies carried out through literature review. The findings show how 
different social actors position themselves in the controversy, revealing a pattern 
of behavior consistent with their position in the research, production, and com-
mercialization of this new nanomaterial. While a group of actors, aligned with the 
interests of AgNP producers, proposed the restriction of mandatory and AgNP-
specific regulation, another group of more heterogeneous actors, identified with 
the interests of workers and consumers, demanded more scientific and technical 
information and stricter health protection measures.
Keywords: nanosilver, risks, recommended exposure limits, regulation,  
occupational health
1. Introduction
The regulation of chemical substances involves a difficult negotiation between 
social actors to translate often controversial scientific evidence about risks and 
safety into legal norms. When the regulation faces chemical substances with 
uncertain risk, as in many of the nanomaterials, the difficulties increase.
This article addresses the public discussion of a proposal for a voluntary guide 
to regulate the exposure limits to silver nanoparticles (AgNP) in workplaces in the 
United States. The draft guide, known as Recommended Exposure Limits (REL), 
was prepared by the National Institute for Occupational Safety and Health (NIOSH) 
on-demand from the Centers for Disease Control and Prevention (CDC), and went 
through two stages of discussion and rework during 2016–2018. We examine the 
public online discussion of both drafts by different social actors, basically academics, 
business organizations, and non-governmental organizations (NGOs).
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Analyzing this discussion required placing nanotechnologies in their histori-
cal and socio-technical context. Nanotechnology is the intentional manipulation 
of matter to form new structures with a dimension smaller than 100 nanometers. 
Nanoparticles have particular physical–chemical properties (electrical, optical, 
magnetic, thermal, mechanical) and are different from the same material on a 
larger scale [1]. The interaction of nanoparticles with biological systems is highly 
unpredictable and their use may involve unknown risks [2].
From mid-2000s there was an explosion of nanotechnology products in the 
market. Although there are no detailed records, StatNano [3] registered 8 452 
products until November 2018, present in almost all economic sectors.
The development of this emerging technology coincides with the wake-up call 
by the World Health Organization and the United Nations Environment Program 
on the global pandemic caused by toxic chemicals [4]. These organizations indicate 
that about five million people die annually from the exposure and handling of 
chemical substances and contact with consumer items that contain them [5, 6].
Silver is a metal known both for its toxicity and for its healing effects since 
ancient times [7]. Currently, its use in the form of nanoparticles is blossoming. 
The inventory of nanotechnology products of the Woodrow Wilson International 
Center for Scholars identified 442 using AgNP, and reports that silver is the most 
commonly used nanomaterial in the whole set of products [8, 9]. The antibacte-
rial properties of AgNP justify its use in textiles, food packaging, paints, toys, 
environmental technologies, cosmetics, implants, and other medical devices; 
they are also used in the electronics industry (semiconductor printing, radio 
frequency identifiers, flexible circuits, solar panels) [10–12]. The United States 
produced 20 tons of AgNP in 2010; in 2014 between 450 and 542 tons were 
produced at a word level [13].
Toxic effects of AgNP on the human organism have been detected when certain 
exposure levels are exceeded [14]. In the workplace, the AgNP enter the body 
mainly through inhalation. The final destination within the organism is uncer-
tain. Whereas there was a consensus to consider that were the lungs, more recent 
research has showed that they can move from the lungs to the liver, and eventually 
to the spleen and kidneys, accumulating [12], thus exposing workers to a variety of 
potential health threats. These characteristics of AgNP have raised the concern of 
CDC of the United States, which has recommended NIOSH to develop a voluntary 
guide (REL) of permissible exposure for AgNP [15].
The toxicity of silver in larger sizes, when certain exposure limits are exceeded, 
is already widely known, causing, for example, argyria, and there are safety regula-
tions in this regard [16]. With the increasing use of AgNP, a debate arises about 
whether, in smaller sizes, such as nanoparticles, the toxicity of silver remains the 
same, as some of the actors who participated in the public consultation analyzed 
here argue, or if toxicity manifests itself differently, as other actors claim.
Regarding occupational safety, there are mandatory regulations and voluntary 
guides. In the United States, a chain of regulations can be identified. The first is the 
Occupational Exposure Limits (OEL), which are scientific studies about the maxi-
mum acceptable limit of particles in workplaces of hazardous substances of certain 
material or class of materials. The OELs are established considering functional 
categories (exposure period time according to the degree of concentration, maxi-
mum exposure, and an emergency category when danger is imminent).
Based on OEL, mandatory workplace standards called Permissible Exposure Limit 
(PEL) are developed. These are prepared by the Occupational Safety and Health 
Administration (OSHA). Voluntary standards, such as the Recommended Exposure 
Limit (REL) examined in this chapter can also be developed, often based on OELs. 
These are elaborated by NIOSH.
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On December 18, 2015, the NIOSH put out a first REL draft, entitled Current 
Intelligence Bulletin: Health Effects of Occupational Exposure to Silver Nanomaterials 
[13] for public consultation. This received comments from different institutions, 
organizations and scientists, from which a second draft was prepared [13] and 
made public on August 24, 2018. The latter also underwent public consultation, 
which ended in November 2018. This article examines the two drafts with their 
corresponding comments available on the website of CDC (https://www.regula-
tions.gov/docket?D=CDC-2016-0001). The analysis considers only the comments 
from the public, since the comments from peer reviewers asked by the agency are 
anonymous and not publicly available.
The antecedent of this draft REL is the existence of a PEL based, in turn, on 
a 1988 OEL, which controls the exposure to silver in the workplace. The OSHA 
imposes a PEL of 10 μm/m3 for soluble and powdered silver. Both, the OEL study 
and the mandatory exposure limit established in the PEL, refer to silver in larger 
sizes; no standard exists, be it an OEL or a PEL, for nanosized silver. What is under 
construction, and is discussed here, is a voluntary guide, a REL. It is important to 
note that, at the beginning of this process, when NIOSH based the first draft of the 
REL for silver in nanosize on the existing OEL that referred to silver in larger sizes, 
implicitly proposed an equivalent regulatory treatment for silver and nanosilver. 
However, as the consultation process advanced, and critical comments were made 
on this point, NIOSH responded with a second draft that distinguishes nanopar-
ticles in the air, establishing a much lower maximum exposure of 0.9 μm/m3 and 
leaving the original exposure limit of 10 μm/m3 for particles in dust, smoke, and 
soluble compounds. As will be seen, the public consultation evidenced that there 
are opposing positions regarding whether the OEL for silver is sufficient to elabo-
rate a REL for nanosilver [11, 17].
The commentaries correspond to the following social actors: PISC, PBNS, NIA, 
CTA, SNWG, Faustman, Oberdörster, and Fox, briefly described in what follows.
• PETA International Science Consortium Ltd (PISC) is an international  
consortium aimed at promoting strategies to replace the use of animals in 
experiments [18].
• Pennsylvania Bio Nano Systems (PBNS) is a one-person company that advises 
nanotechnology companies regarding technical regulatory matters [16, 19].
• Nanotechnology Industries Association (NIA) is an association of companies and 
other entities related to the production and commercialization of nanotechnol-
ogy products. It advises national and international institutions and organisms, 
such as the OECD and the ISO, and has the goal of promoting the use of 
nanotechnologies [20].
• International Center for Technology Assessment (CTA) is an NGO oriented to 
assess the social impacts of technologies [21].
• Silver Nanotechnology Working Group (SNWG) is an enterprise organiza-
tion that promotes scientific knowledge production and public information 
regarding the beneficial use of silver nanoparticles in industrial products and 
final consumption [22].
• Elaine Faustman is an investigator for the Institute Risk Analysis and Risk 
Communication, and the Department of Environmental and Occupational Health 
Sciences, at the University of Washington, WA [23].
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• Guenter Oberdörster is a recognized scientist specialized in the toxicology of 
nanomaterials at the Department of Environmental Medicine, of the University 
of Rochester, NY [17].
• Mary A Fox is an assistant professor at Johns Hopkins Bloomberg School of Public 
Health, and Co-director of the Risk Sciences and Public Policy Institute [24].
2. Methodology
This qualitative investigation was elaborated in four stages, that go from the 
general to the particular, placing the problem to analyze, which is the regulation 
of AgNP, within a broader historical and socio-technical perspective. The first 
three stages were built upon a revision of literature based on consultations to the 
Scopus, Web of Science, and PubMEd databases, and the analysis of documents 
and databases of products that use nanotechnologies. The last stage was developed 
through content analysis of the interventions of the different actors in the public 
consultation of the REL document.
The first stage consisted of tracing the historical and socio-technical context in 
which nanotechnologies arose, which allowed us to underscore two aspects. First, 
the fast growth of nanotechnology products since the beginning of the century, 
most of them without regulation. Second, the entry of new chemical products such 
as silver nanoparticles into the market, without prior assessment of their risks, 
occurred in the context of the pandemic caused by toxic chemicals used in everyday 
consumer goods, as stated by the Organization World Health (WHO) and UNDP 
(United Nations Development Program).
The second stage was aimed at identifying the main characteristics of AgNP, 
both in technical terms and concerning their potential risks.
The third stage was to describe the object of study, that is, the voluntary guide-
line for AgNP regulation in preparation. This required explaining the main aspects 
and restrictions of the preparation of a voluntary guide such as a REL, which led 
to the identification of the contradictory nature of the process of transforming 
technical-scientific risk criteria into legal standards. Next, the actors (organizations 
or individuals) who commented on the drafts were identified.
The fourth stage consisted of the analysis of the NIOSH draft document and the 
comments made by the various actors in the public consultation. The content analy-
sis was based on the information obtained in the previous stages. A voluntary guide 
such as the REL adapts scientific-technical information regarding the hazards/risks 
of a work environment with AgNP, to legal norms that involve different actors: The 
State, private companies, and workers. The first actor creates (and enforces when 
it is the case) the regulation; the second is the target group of the regulation, and 
the last group is the main subject of risk and beneficiary of the regulation. From the 
two fields in interaction, scientific-technical and legal, three dimensions of content 
analysis were derived, which were formulated as three specific questions to examine 
the positions defended by the different actors who participated in the discussion of 
the voluntary guide drafts.
First, based on the available methods, techniques and information, the stan-
dards, both mandatory (PEL) and voluntary (REL), conform to a given state of 
knowledge, feasible for further extension or revision, which, in turn, would lead to 
the updating of the rules. This raises the problem of how and when to regulate and 
limit (or expand) the production and marketing of new chemicals. In the case at 
hand, the question is stated as follows:
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• At what point, regarding the progress in research and development (R&D), 
the production and commercialization of AgNP should a REL and/or a PEL be 
elaborated?
Second, since the knowledge on hazard/risk is always incomplete and subject 
to controversies,
• How is the conflict between insufficient knowledge and administration of 
risks solved?
Third, being the main involved actors, namely the State, the companies, and 
the workers,
• What are the actors’ opinions regarding the level of responsibility on risk (the 
producer, the regulatory organism, or the worker), and what should be the 
degree of access to the relevant information (confidential or public)?
3. Results and discussion
When examining the social actors who commented on the document, clear dif-
ferences in the relationship they maintain with the subject under discussion emerge. 
NIA and SNWG are industrial representatives and PBNS a business advisor. This 
group of three actors has a conflict of interest regarding the subject because their 
final goal is the production and incorporation of AgNP in consumer products and 
their commercialization. PISC is an animal rights defense organization; there-
fore, it has a conflict of interest regarding the in vivo methods of risk assessment. 
Oberdörster, Faustman, and Fox are researchers from research centers who have 
declared no conflict of interest in articles published on the subject. CTA is an NGO, 
based in the United States, aimed at assessing and advising society on the economic, 
ethical, social, environmental and political impacts that result from the application 
of technologies, without a declared conflict of interest, although manifestly biased 
towards workers and consumers. This different location of the actors regarding the 
subject necessarily determines their perspectives.
In the following subsections, we examine the arguments deployed by the actors 
in their commentaries to the document under consultation, organizing them 
around the three questions formulated in the methodology.
I. At what point should REL and/or PEL be elaborated regarding the stage of R&D, 
production and commercialization of the AgNP?
Despite the enormous variety of nanoparticles, and that each one can imply 
different health risks for workers, there is an element in common to all of them: the 
matter in nanoscale shows different biological and physicochemical properties com-
pared to the same matter on a larger scale. Moreover, the same material behaves dif-
ferently within the range of 1 to 100 nm, depending on its shape, crystallography, 
number of dimensions in the nanoscale and other characteristics. Nanoparticles’ 
behavior also varies according to the route through which they enter the organism 
and the exposure time. Regarding silver, and without considering the nano size, 
several studies indicate different toxicity depending on the way it is presented 
(dust, soluble, etc.) [16], which already warns that size is associated with distinct 
toxic effects. In this context, it is relevant to ask: why do new chemicals enter 
the market without toxicity analysis, or assessed on the basis of methodologies 
developed for the matter in a larger size, as in the case of nanoparticles? Given the 
current pandemic caused by toxic chemicals, the uncertainty about the risks derived 
from the properties of the nano-sized matter, and the existence of sophisticated risk 
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assessment techniques, it is necessary to understand why there is such a temporary 
lag between entry of products with AgNP to the market and their regulation.
In the REL discussion, NIOSH presented a first draft of the document in 2016, 
then corrected it in 2018. In none of the versions, mention was made on the contra-
diction between the elaboration of a REL while AgNP continued to enter the market 
in various products without any specific regulation. In this way, the NIOSH is trying 
to “manage the existing situation”, adopting an effective risk management approach, 
without any mention to the possibility of modifying the path of production and 
consumption by controlling the market. There is also no mention of the fact that 
the regulation under discussion was already delayed, considering the increasing 
commercialization of products with AgNP since mid-2000s.
Within the commentators, only the CTA refers to this issue and advocates for 
a moratorium on the commercialization until there is enough data confirming the 
safety of AgNP:
No data should mean no new production […] companies should stop manufactur-
ing unapproved nanosilver products [21].
Except for this actor, the NIOSH proposals, and the commentators, take as a 
natural fact the marketing of products without sufficient data regarding their safety. 
In doing so, they promote an ex-post safety policy, instead of a preventive policy.
II. How is the conflict between insufficient knowledge and administration of risk 
solved? The question of uncertainty.
The discussion evidences three conflictive areas regarding knowledge and 
uncertainties on the dangers and risks of AgNP. The first one refers to the relation-
ship between size and toxicological effects. The second relates to the way in which 
scientific data is interpreted and transformed into legal rules. The last conflictive 
point has to do with the validity of scientific methods and their limitations.
i. The first area of controversy is the distinction between the effects of silver 
vis a vis nanosilver. The industrial actors and their advisors affirm that 
nanosilver has the same toxicological behavior as silver in a larger size and 
that there is already a PEL issued by OSHA on silver, which would make 
unnecessary the elaboration of a specific REL on AgNP. As already said, the 
first draft of the NIOSH proposal also considered the risks of AgNPs and 
silver in larger size equivalent. Later on, NIOSH changed this perspective 
and acknowledged the different risks of silver in nanoscale and larger sizes 
[15].1 The industry working group commented:
SNWG is extending support of the Agency’s recommendation that effective risk 
management control practices be implemented so that worker exposures to all 
forms of silver, including silver nanomaterials, do not exceed the NIOSH REL of 
10 μg/m3 (8-hour time-weighted average) for silver metal dust, fume, and soluble 
compounds measured as a total airborne mass concentration. […] workers will be 
more than adequately protected from any potential harmful exposures to all forms 
of silver, including nanosilver. […] In light of some of the uncertainties concerning 
nanosilver, the SNWG believes that the toxicity of nanosilver is not significantly 
different from bulk or dissolved Ag (colloidal silver) [22].
1 Here is not the place to develop on this issue, but the reader must consider both the economic and 
political power of the chemical industry and the neoliberal phase of capitalism that has been replacing 
the control of the State over private enterprise by business self-responsibility, a transition from regula-
tion to governance, from hard to soft law [25].
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The industry working group begins supporting NIOSH’s recommendation, 
but the support is limited to the first draft of the document, where 10 μg/m3 was 
suggested as a limit, the same limit that OSHA uses for silver in larger size. In the 
following sentence, the commentator explicitly identifies silver and nanosilver as 
equal for risk analysis; and, in the last one, emphasizes that the uncertainties are the 
same for silver and nanosilver. In summary, SNWG argues that there is no need for 
a specific standard for nanosilver.
From the same opinion is the NIA,
[…] the Association insists that silver nanomaterials do not present a different 
toxicological profile to other forms of silver, including colloidal silver. The antimi-
crobial action of silver, and therefore its toxicological profile, originates in silver 
ions (Ag+) and may not be attributed to the nanoparticles themselves [20].
PBNS, an industry consultant entity, considers argyria as the final point in the 
organism of silver potential health risks, and argues that the maximum permis-
sible contemplates all types of particles, so there would be no difference between 
nano and large-scale silver, and, since there is an OSHA PEL for the larger size, the 
NIOSH should not insist on the specificity of the nanosize. However, contradicto-
rily, PBNS recognizes that nanomaterials can present “unexpected properties”; but, 
if the NIOSH understands that the endpoint of silver is argyria, there would not be, 
according to PBNS, a novel effect, and using the nano concept would be incorrect:
In selecting argyria as the valid endpoint, there is then no novel use, nor first time 
exposure nor unexpected property. Yet, using the term nanomaterial implies that 
there should be a particle size dependence [19].
The entire PBNS comment goes in the direction of invalidating the specificity of 
nano and suggesting to follow the OSHA’s already approved criteria based on silver 
in a larger size [19].
It is worth noticing that the three industrial actors’ arguments do not rebut the 
scientific articles published over the past two decades, which provide evidence 
about the different behavior of AgNP and silver in a larger size -- see, for example, 
the systematic review of Akter et al. [14]. In doing so, they are simply ignoring the 
available scientific information that does not fit their interests. Neither they refer to 
the current uncertainty involving the risks of the matter at the nanoscale, an aspect 
which is considered a crucial issue in the NIOSH first draft, which demands atten-
tion to the likely different risks associated with AgNP in the air, in the solid and 
liquid forms, due to the different routes of introduction into the organism.
The animal defense NGO (PISC), for its part, only emphasizes the need to 
replace analysis in vivo with in vitro and in silicon; and by not questioning the equal-
ization of risks in nano and larger scales stated in the first draft of the document, 
reinforces the business position.
The remaining actors, the NGO and the independent researchers, recognize that 
nanosilver implies a different risk than silver in a larger size. Independent research-
ers, for example, explicitly call attention to the specific risks associated with nano 
size. Faustman argues that:
While an OEL for micro-sized silver dust and silver fumes of 10 μg/m3 is in place, 
we believe that the physicochemical properties of AgNPs allow for additional 
health risks not observed from exposure to micro-sized particles [23].
Oberdörster also stresses the specificity of AgNP by emphasizing the different 
risks of inhaled nanoparticles, as well as indicating the liver as the final point of 
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destination in the organism of the nanosized silver [17]. CTA, meanwhile, shows 
that there is a much wider variety of AgNP on the market than the NIOSH draft 
recognizes; and that each of these varieties may have different risks, so a specific 
REL is necessary for each case [21]. Fox points out the need to specify when refer-
ring to pure AgNP, and, perhaps, it would be necessary to establish different RELs 
for soluble and insoluble nanoparticles [24].
ii. The second area of controversy has to do with the degree of correspond-
ence between the scientific references provided by the NIOSH document 
(bibliography) and its normative conclusions; that is, between the scientific-
technical information and its legal adaptation.
NIA calls to reduce the scope of the regulation to a specific form of nanopar-
ticles, spherical not covered; just because the bibliography of the NIOSH draft only 
includes this modality.
[…] document scope should be revised to reflect the data presented in the Draft 
Bulletin. While NIOSH mentions the ISO definition of a nanomaterial, which 
includes particles, plates and wires, studies mentioned in the Draft Bulletin mostly 
address spherical silver nanoparticles. In addition, the studies in the document 
mostly focus on uncoated silver nanoparticles. As a result, the Draft Bulletin should 
explicitly focus on health effects of uncoated spherical silver nanoparticles [20].
There is a huge variety of nanoparticles, and the regulation cannot deal with 
them one by one, but the industry takes refuge in this limitation of the cited litera-
ture to avoid or reduce the scope of the regulation. The industrial consultant PNBS 
takes a similar stand, asking for restricting the scope of the REL to strictly adjust it 
to the literature displayed in the document:
Narrow the current REL (10 μg/m3) to substantively spherical primary particles, 
their aggregates and agglomerates, and caution that the REL does not extend to 
shapes with high aspect ratios […] Narrow the current REL to uncoated silver-
metal- particles [19].
In the opposite direction, proposing to expand the scope of the REL, the CTA 
claims that the intended maximum of 100 nanometers established by the REL 
should be extended to 1,000 nm [21] and, to that end, introduces the argument that 
other governmental agencies, such as the FDA, have extended the analysis of AgNPs 
to 1000 nm, when it merits [26]:
WHAT SIZE IS NANO? This review simply uses the narrow US government 
definition for “nano,” i.e. 1-100 nm. The NIOSH definition would be enhanced if 
it used the expanded standard used by the FDA, i.e. companies are asked to report 
as “nano” any change in size below 1000 nm that changes the properties of the 
chemical [21].
The industry supports the 100 nm limit for nanosize and considers that existing 
analyses of silver in a larger size are appropriate to assess risks. SNWG, for example, 
supports the use by NIOSH of the categories of exposition of the existing PEL 
issued by OSHA. In doing so, it also agrees with equivalent toxicity assessments 
between nano-size and larger-size as stated in the NIOSH first draft [22].
Therefore, while independent scientists and the environmental NGO claim the 
necessity to expand the bibliographic references to better assess the risks of AgNP, 
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and raise questions on the ones used [24], in order to construct a broader regula-
tion, companies prefer to keep the existing bibliographic references and seek to 
restrict the regulation scope.
iii. Finally, the third area of controversy over risk uncertainties regards the 
validity of scientific methods and their limitations. Currently, most risk ana-
lyzes include various techniques, in vitro, in vivo, in silicon. The analysis in 
silicon has expanded due to its speed, economy, and the possibility of stand-
ardizing the procedures, and also because of the ethical concerns regarding 
tests on animals. PISC, for example, suggests that NIOSH should replace 
analysis in vivo with in vitro and in silicon [27] and justifies this demand not 
only because of ethical but also methodological reasons, particularly regard-
ing the uncertainties of extrapolating information from animals to humans:
The dissolution of silver nanoparticles (AgNPs) in different physiological environ-
ments can be addressed using alternative methods (including in vitro and ex vivo), 
which are considered a vital tool in understanding AgNP behavior in vivo.
[…] Of note here is that there are many uncertainties in extrapolating toxicity 
outcomes from animals to humans, including variations in responses to chemicals 
in different species and strains of animals, gender differences within species of ani-
mals, as well as different toxic thresholds between species including humans [27].
Some independent researchers have criticized NIOSH’s preference for the appli-
cation of the PBPK method to AgNP, rather than relying on research with in vivo 
methods. While the PBPK method is in silicon, the one used as the basis in indepen-
dent studies extrapolates results from an analysis in vivo [11], which, among other 
things, suggests the liver instead of, or in addition to, the lungs, as the toxicological 
endpoint, as the first draft of the NIOSH suggests [23]. Moreover, the methods 
in silicon have been criticized by many epidemiologists because even when using 
several variables, they are always restricted compared to the number of variables 
present in a living organism [28]. Computerization also implies that the selection of 
the variables to be considered may be subject to manipulation [29, 30]. Oberdörster 
suggests that PBPK should not be used due to a lack of reliability:
REL are not well justified, because of either questionable PBPK modeling using 
disputed data or of rather simplistic unscientific extrapolation [17].
In the opposite position, SNWG applauds the use of the PBKP on which the 
NIOSH relies:
In light of these standards based on argyria, the endpoint of concern, the SNWG 
applauds the use of the Bachler et al., 2013 PBPK model for silver nanoparticles 
to evaluate the potential adverse effects of working lifetime exposure to silver 
nanoparticles at the current NIOSH REL for silver (10 ug/m3, 8-hr TWA concen-
tration of soluble or insoluble silver, total airborne particle mass sampling). This 
PBPK model was developed based on data in rats, extrapolated to humans, and 
validated with limited bioassay data in humans [22, 31].
Many of the arguments deployed in the comments to the public consulta-
tion are not based on scientific information, but reveal how participants use the 
inconsistencies of the draft to limit, extend, or reject conclusions. This is evident, 
for instance, when the toxicological effects of silver in nano and larger scales are 
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considered equivalents in spite of mounting evidence indicating they are not; or 
when it is suggested to restrain the regulation to the form of nanoparticles men-
tioned by the bibliography of the first draft, instead to enlarging the references to 
include the as much scientific information on diverse nanoparticle forms as pos-
sible; or when the limitations of scientific techniques are not discussed in terms of 
their implications for the effective protection of the workers’ health. Such examples 
reveal the intricacy of the process of regulation, in which scientific information is 
subjected to diverse interpretations from the perspectives and interests of different 
social actors.
III. What are the perspectives of the actors regarding the hierarchy of responsibility 
on risk (producer, regulatory body, worker), and the degree of access to information 
(confidentiality or disclosure)?
Risk analysis considers the potential hazard and the degree of exposure of the 
worker [32, 33]. Exposure can be reduced by an uncontaminated environment or 
using protective equipment. The legislation aims to avoid hazards, maintaining a 
pollution-free environment in the first instance, and when this is not possible, using 
personal protective equipment [34]. The REL draft reproduces this hierarchy of 
controls in its recommendations. Although this hierarchy of protection procedures 
is a widely established legal fact, the emphasis on one or another alternative is 
significant in the position of the different actors. Thus, for example, CTA is explicit 
in emphasizing hazard control: “workplace controls, not respirators are needed” [21], 
and at large:
NIOSH, however, needs to stress even more strongly that in the absence of suf-
ficient data on the inhaled toxicity of nanosilver products, that it is EXTREMELY 
important that workplaces implement a hierarchy of controls that keep workers 
from breathing any nanosilver. NIOSH needs to strengthen its risk management 
control practices to note that respirators will not be adequate to protect workers and 
that avoiding exposures is the best way to protect workers [21].
The claim is valid because the REL is a voluntary guide, and, as long as there is 
no PEL from which the State can impose a firmer measure, the different approaches 
on how to avoid hazards lead to different responsibilities. Maintaining the work 
environment without risk is the responsibility of the employer, while the use of 
personal protective equipment places the responsibility on the worker. This criti-
cism was assumed by NIOSH in the second draft:
The revised document recommends using the hierarchy of controls, encouraging the 
elimination or substitution of silver nanomaterials before employment of engineer-
ing controls, with PPE, including respirators, being the final and least preferable 
control [35].
Responsibility for risks is intricately linked to the availability of information. 
If workers do not have information about the materials they handle, their hazards, 
and the risk to which they are subjected, they can hardly adopt a preventive attitude 
towards illnesses and accidents. The publicity or confidentiality of the informa-
tion that the companies handle is a point of contention. CTA asks NIOSH to use 
information about the effects of AgNP available at other government agencies, such 
as the EPA and the FDA, information that these agencies have because they have 
authorized the entry of products with AgNP into the market [21]. The given answer 
reveals that there are confidentiality clauses that frequently prevent this circulation 
of information:
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NIOSH collaborates with other Federal agencies when possible on chemical assess-
ments to avoid a duplication of effort [35].
SNWG insists on the confidentiality of potential requests for information by 
the NIOSH:
In regard to the research needs discussed in Section 8 of the NIOSH document, 
one of the functions of the Silver Nanotechnology Working Group is to identify, 
gather and consolidate industry data in an anonymous manner to protect CBI 
(Confidential Business Information). If such a mechanism is needed by NIOSH 
to bring forth needed data as listed on p. 120–121 of the External Review Draft 
[3] in a manner consistent with CBI, the SNWG would be glad to serve in such a 
capacity [22].
The analytical answer to the third question leads to a similar conclusion to the 
previous two. The three industrial actors agree to reduce the available scientific 
information, or raise doubts about its relevance, to ensure the confidentiality of 
data on the materials used in production. In the opposite position are the inde-
pendent researchers, who insist on expanding the range of literature and methods 
related to the subject, and on sustaining the differences between silver and 
nanosilver. In addition to this, the environmental NGO demands to consolidate the 
employer’s responsibility instead of the workers and asks for the dissemination of 
technical information.
4. Conclusions
The analysis of the voluntary guide regarding workers’ exposure to the risks 
of AgNP in occupational environments, as well as the comments made by several 
actors, allow us to draw some conclusions. The first and most general is that, except 
for one commentator, the issue under discussion is considered within a broader con-
text in which the entrance of novel materials into the market, without assessment of 
their safety, is taken as a given fact. Therefore, the proposals are limited to admin-
istering the state of affairs, that is, the production and marketing of AgNPs and the 
commodities that incorporate them, notwithstanding the existence of scientific 
evidence of risks for the workers operating in its production or handling. Regulation 
faces an economic dynamic that overcomes it and aims just to lessen its side effects.
The second conclusion is that the commentators, despite responding individu-
ally to the draft, can be grouped analytically into two large groups, according to the 
coincidence of opinions. The first group responds to the interests of the producers 
and marketers of AgNP. Their views agree in restricting as much as possible the 
advent of mandatory regulatory measures. This is explicit in their arguments about 
the equivalent risks of AgNPs and silver in larger sizes. It is also evident when 
their spokesmen raise doubts about potential risks of AgNP; when they prioritize 
confidentiality over information on production processes, and when they derive 
the responsibility on risk control on workers. The second group, with less cohesion, 
demands to broaden the spectrum of scientific-technical information and to limit 
the production and marketing of commodities with AgNP until they are proved 
safe, in order to protect workers and consumers. The first group, more compact 
and convergent in their opinions, is clearly identified with business interests. The 
second, more dispersed, represent the interests of workers and consumers, as well 
as independent intellectuals who demand further investigation.
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The third conclusion regards the role, largely transparent and responsible, of 
the government agency that conducted the process, the NIOSH. The transparency 
approach lies in opening the draft for public comments, as well as the flexibility 
demonstrated in the changes made in the second version of the document respond-
ing to the comments received. For example, a modification from the originally 
proposed exposure limit of 10.0 μg/m 3 for all particulate forms of AgNP to a 0.9 μg/
m3 in the specific case of AgNPs in the air. It is also relevant to highlight that the 
second draft included a specific mention of the hierarchy of risk control, placing 
the producer in the first position and secondarily the worker, specifying that the 
priority is to avoid hazards in the work environment, and only as a last resource, 
individual protection equipment must play its role.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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